Sero-diagnosis of tuberculosis with A60 antigen enzyme-linked immunosorbent assay: failure in HIV-infected individuals in Ghana.
Identifieur interne : 000847 ( PubMed/Checkpoint ); précédent : 000846; suivant : 000848Sero-diagnosis of tuberculosis with A60 antigen enzyme-linked immunosorbent assay: failure in HIV-infected individuals in Ghana.
Auteurs : T S Van Der Werf [Ghana] ; P K Das ; D. Van Soolingen ; S. Yong ; T W Van Der Mark ; R. Van Den AkkerSource :
- Medical microbiology and immunology [ 0300-8584 ] ; 1992.
Descripteurs français
- KwdFr :
- Adulte, Anticorps anti-VIH (sang), Anticorps antibactériens (sang), Antigènes bactériens, Erreurs de diagnostic, Humains, Immunoglobuline G (sang), Infections à VIH (), Infections à VIH (immunologie), Sensibilité et spécificité, Test ELISA (), Tuberculose pulmonaire (), Tuberculose pulmonaire (diagnostic), Tuberculose pulmonaire (immunologie), VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie), VIH-2 (Virus de l'Immunodéficience Humaine de type 2) (immunologie).
- MESH :
- diagnostic : Tuberculose pulmonaire.
- immunologie : Infections à VIH, Tuberculose pulmonaire, VIH-1 (Virus de l'Immunodéficience Humaine de type 1), VIH-2 (Virus de l'Immunodéficience Humaine de type 2).
- sang : Anticorps anti-VIH, Anticorps antibactériens, Immunoglobuline G.
- Adulte, Antigènes bactériens, Erreurs de diagnostic, Humains, Infections à VIH, Sensibilité et spécificité, Test ELISA, Tuberculose pulmonaire.
English descriptors
- KwdEn :
- Adult, Antibodies, Bacterial (blood), Antigens, Bacterial, Diagnostic Errors, Enzyme-Linked Immunosorbent Assay (methods), Enzyme-Linked Immunosorbent Assay (statistics & numerical data), HIV Antibodies (blood), HIV Infections (complications), HIV Infections (immunology), HIV-1 (immunology), HIV-2 (immunology), Humans, Immunoglobulin G (blood), Sensitivity and Specificity, Tuberculosis, Pulmonary (complications), Tuberculosis, Pulmonary (diagnosis), Tuberculosis, Pulmonary (immunology).
- MESH :
- chemical , blood : Antibodies, Bacterial, HIV Antibodies, Immunoglobulin G.
- complications : HIV Infections, Tuberculosis, Pulmonary.
- diagnosis : Tuberculosis, Pulmonary.
- immunology : HIV Infections, HIV-1, HIV-2, Tuberculosis, Pulmonary.
- methods : Enzyme-Linked Immunosorbent Assay.
- statistics & numerical data : Enzyme-Linked Immunosorbent Assay.
- Adult, Antigens, Bacterial, Diagnostic Errors, Humans, Sensitivity and Specificity.
Abstract
In order to assess the diagnostic usefulness of the A60 (ANDA Biological, Strassbourg, France) sero-diagnostic enzyme-linked immunosorbent assay (ELISA) kit for tuberculosis in Africa, sera of 53 pulmonary smear-positive tuberculosis (TB) patients, 30 apparently healthy control subjects and 6 AIDS suspects were sampled in Agogo Hospital in the forest area of Ghana. These sera were analyzed for antibodies to HIV-1 and HIV-2, and IgG-antibodies to the A60 BCG-antigen, while the non-HIV individuals were tested for total IgG levels. One healthy control subject, all of 6 AIDS suspects and 7 of the TB patients has HIV infections. In the non-HIV TB group, the sensitivity and specifity of the A60 ELISA was 78% and 86%, respectively, which was much poorer than expected from published reports about the A60 test. The A60 test failed, completely however, to discriminate between TB and non-TB in the HIV-positive group. In the non-HIV groups, total IgG levels were significantly higher in TB patients than in controls. It seems that the usefulness of the A60 ELISA test to diagnose tuberculosis is very limited in this high-incidence area, and that it seems to be of no value in patients infected with HIV.
PubMed: 1406459
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:1406459Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sero-diagnosis of tuberculosis with A60 antigen enzyme-linked immunosorbent assay: failure in HIV-infected individuals in Ghana.</title><author><name sortKey="Van Der Werf, T S" sort="Van Der Werf, T S" uniqKey="Van Der Werf T" first="T S" last="Van Der Werf">T S Van Der Werf</name><affiliation wicri:level="1"><nlm:affiliation>Agogo Hospital, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Agogo Hospital</wicri:regionArea></affiliation></author><author><name sortKey="Das, P K" sort="Das, P K" uniqKey="Das P" first="P K" last="Das">P K Das</name></author><author><name sortKey="Van Soolingen, D" sort="Van Soolingen, D" uniqKey="Van Soolingen D" first="D" last="Van Soolingen">D. Van Soolingen</name></author><author><name sortKey="Yong, S" sort="Yong, S" uniqKey="Yong S" first="S" last="Yong">S. Yong</name></author><author><name sortKey="Van Der Mark, T W" sort="Van Der Mark, T W" uniqKey="Van Der Mark T" first="T W" last="Van Der Mark">T W Van Der Mark</name></author><author><name sortKey="Van Den Akker, R" sort="Van Den Akker, R" uniqKey="Van Den Akker R" first="R" last="Van Den Akker">R. Van Den Akker</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1992">1992</date><idno type="RBID">pubmed:1406459</idno><idno type="pmid">1406459</idno><idno type="wicri:Area/PubMed/Corpus">000687</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000687</idno><idno type="wicri:Area/PubMed/Curation">000687</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000687</idno><idno type="wicri:Area/PubMed/Checkpoint">000687</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000687</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Sero-diagnosis of tuberculosis with A60 antigen enzyme-linked immunosorbent assay: failure in HIV-infected individuals in Ghana.</title><author><name sortKey="Van Der Werf, T S" sort="Van Der Werf, T S" uniqKey="Van Der Werf T" first="T S" last="Van Der Werf">T S Van Der Werf</name><affiliation wicri:level="1"><nlm:affiliation>Agogo Hospital, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Agogo Hospital</wicri:regionArea></affiliation></author><author><name sortKey="Das, P K" sort="Das, P K" uniqKey="Das P" first="P K" last="Das">P K Das</name></author><author><name sortKey="Van Soolingen, D" sort="Van Soolingen, D" uniqKey="Van Soolingen D" first="D" last="Van Soolingen">D. Van Soolingen</name></author><author><name sortKey="Yong, S" sort="Yong, S" uniqKey="Yong S" first="S" last="Yong">S. Yong</name></author><author><name sortKey="Van Der Mark, T W" sort="Van Der Mark, T W" uniqKey="Van Der Mark T" first="T W" last="Van Der Mark">T W Van Der Mark</name></author><author><name sortKey="Van Den Akker, R" sort="Van Den Akker, R" uniqKey="Van Den Akker R" first="R" last="Van Den Akker">R. Van Den Akker</name></author></analytic><series><title level="j">Medical microbiology and immunology</title><idno type="ISSN">0300-8584</idno><imprint><date when="1992" type="published">1992</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antibodies, Bacterial (blood)</term><term>Antigens, Bacterial</term><term>Diagnostic Errors</term><term>Enzyme-Linked Immunosorbent Assay (methods)</term><term>Enzyme-Linked Immunosorbent Assay (statistics & numerical data)</term><term>HIV Antibodies (blood)</term><term>HIV Infections (complications)</term><term>HIV Infections (immunology)</term><term>HIV-1 (immunology)</term><term>HIV-2 (immunology)</term><term>Humans</term><term>Immunoglobulin G (blood)</term><term>Sensitivity and Specificity</term><term>Tuberculosis, Pulmonary (complications)</term><term>Tuberculosis, Pulmonary (diagnosis)</term><term>Tuberculosis, Pulmonary (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Anticorps anti-VIH (sang)</term><term>Anticorps antibactériens (sang)</term><term>Antigènes bactériens</term><term>Erreurs de diagnostic</term><term>Humains</term><term>Immunoglobuline G (sang)</term><term>Infections à VIH ()</term><term>Infections à VIH (immunologie)</term><term>Sensibilité et spécificité</term><term>Test ELISA ()</term><term>Tuberculose pulmonaire ()</term><term>Tuberculose pulmonaire (diagnostic)</term><term>Tuberculose pulmonaire (immunologie)</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie)</term><term>VIH-2 (Virus de l'Immunodéficience Humaine de type 2) (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Bacterial</term><term>HIV Antibodies</term><term>Immunoglobulin G</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Infections</term><term>Tuberculosis, Pulmonary</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Tuberculosis, Pulmonary</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Tuberculose pulmonaire</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à VIH</term><term>Tuberculose pulmonaire</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term><term>VIH-2 (Virus de l'Immunodéficience Humaine de type 2)</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV Infections</term><term>HIV-1</term><term>HIV-2</term><term>Tuberculosis, Pulmonary</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Enzyme-Linked Immunosorbent Assay</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps anti-VIH</term><term>Anticorps antibactériens</term><term>Immunoglobuline G</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Enzyme-Linked Immunosorbent Assay</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Antigens, Bacterial</term><term>Diagnostic Errors</term><term>Humans</term><term>Sensitivity and Specificity</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Antigènes bactériens</term><term>Erreurs de diagnostic</term><term>Humains</term><term>Infections à VIH</term><term>Sensibilité et spécificité</term><term>Test ELISA</term><term>Tuberculose pulmonaire</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In order to assess the diagnostic usefulness of the A60 (ANDA Biological, Strassbourg, France) sero-diagnostic enzyme-linked immunosorbent assay (ELISA) kit for tuberculosis in Africa, sera of 53 pulmonary smear-positive tuberculosis (TB) patients, 30 apparently healthy control subjects and 6 AIDS suspects were sampled in Agogo Hospital in the forest area of Ghana. These sera were analyzed for antibodies to HIV-1 and HIV-2, and IgG-antibodies to the A60 BCG-antigen, while the non-HIV individuals were tested for total IgG levels. One healthy control subject, all of 6 AIDS suspects and 7 of the TB patients has HIV infections. In the non-HIV TB group, the sensitivity and specifity of the A60 ELISA was 78% and 86%, respectively, which was much poorer than expected from published reports about the A60 test. The A60 test failed, completely however, to discriminate between TB and non-TB in the HIV-positive group. In the non-HIV groups, total IgG levels were significantly higher in TB patients than in controls. It seems that the usefulness of the A60 ELISA test to diagnose tuberculosis is very limited in this high-incidence area, and that it seems to be of no value in patients infected with HIV.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1406459</PMID><DateCreated><Year>1992</Year><Month>11</Month><Day>23</Day></DateCreated><DateCompleted><Year>1992</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2017</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0300-8584</ISSN><JournalIssue CitedMedium="Print"><Volume>181</Volume><Issue>2</Issue><PubDate><Year>1992</Year></PubDate></JournalIssue><Title>Medical microbiology and immunology</Title><ISOAbbreviation>Med. Microbiol. Immunol.</ISOAbbreviation></Journal><ArticleTitle>Sero-diagnosis of tuberculosis with A60 antigen enzyme-linked immunosorbent assay: failure in HIV-infected individuals in Ghana.</ArticleTitle><Pagination><MedlinePgn>71-6</MedlinePgn></Pagination><Abstract><AbstractText>In order to assess the diagnostic usefulness of the A60 (ANDA Biological, Strassbourg, France) sero-diagnostic enzyme-linked immunosorbent assay (ELISA) kit for tuberculosis in Africa, sera of 53 pulmonary smear-positive tuberculosis (TB) patients, 30 apparently healthy control subjects and 6 AIDS suspects were sampled in Agogo Hospital in the forest area of Ghana. These sera were analyzed for antibodies to HIV-1 and HIV-2, and IgG-antibodies to the A60 BCG-antigen, while the non-HIV individuals were tested for total IgG levels. One healthy control subject, all of 6 AIDS suspects and 7 of the TB patients has HIV infections. In the non-HIV TB group, the sensitivity and specifity of the A60 ELISA was 78% and 86%, respectively, which was much poorer than expected from published reports about the A60 test. The A60 test failed, completely however, to discriminate between TB and non-TB in the HIV-positive group. In the non-HIV groups, total IgG levels were significantly higher in TB patients than in controls. It seems that the usefulness of the A60 ELISA test to diagnose tuberculosis is very limited in this high-incidence area, and that it seems to be of no value in patients infected with HIV.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Werf</LastName><ForeName>T S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Agogo Hospital, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>P K</ForeName><Initials>PK</Initials></Author><Author ValidYN="Y"><LastName>van Soolingen</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Yong</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>van der Mark</LastName><ForeName>T W</ForeName><Initials>TW</Initials></Author><Author ValidYN="Y"><LastName>van den Akker</LastName><ForeName>R</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Med Microbiol Immunol</MedlineTA><NlmUniqueID>0314524</NlmUniqueID><ISSNLinking>0300-8584</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000907">Antibodies, Bacterial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000942">Antigens, Bacterial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015483">HIV Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C055539">mycobacterial A60 antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>AIDS. 1989;3 Suppl 1:S89-95</RefSource><PMID Version="1">2514761</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 1989;3 Suppl 1:S79-87</RefSource><PMID Version="1">2514760</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Microbiol Immunol. 1989;178(6):323-35</RefSource><PMID Version="1">2693921</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tubercle. 1987 Mar;68(1):65-9</RefSource><PMID Version="1">3660463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tubercle. 1989 Dec;70(4):249-55</RefSource><PMID Version="1">2516670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Scand J Immunol. 1987 Jun;25(6):579-85</RefSource><PMID Version="1">3299680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chest. 1991 Dec;100(6):1687-93</RefSource><PMID Version="1">1959415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1986 Oct 25;2(8513):978</RefSource><PMID Version="1">2877156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Microbiol Immunol. 1989;178(6):315-21</RefSource><PMID Version="1">2515425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1988 Feb 6;1(8580):297</RefSource><PMID Version="1">2893105</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am Rev Respir Dis. 1987 May;135(5):1137-51</RefSource><PMID Version="1">3555188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 1990 Sep 1;301(6749):412-5</RefSource><PMID Version="1">2282396</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Tuberc Res. 1984;21:1-78</RefSource><PMID Version="1">6433674</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Immunol. 1986 Nov;66(2):262-72</RefSource><PMID Version="1">3545572</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am Rev Respir Dis. 1990 Aug;142(2):380-4</RefSource><PMID Version="1">2200315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am Rev Respir Dis. 1981 Jul;124(1):80-7</RefSource><PMID Version="1">7020505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Lett. 1987 Jun;15(2):117-20</RefSource><PMID Version="1">3623633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1989 May-Jun;83(3):410-3</RefSource><PMID Version="1">2617591</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000907" MajorTopicYN="N">Antibodies, Bacterial</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000942" MajorTopicYN="N">Antigens, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003951" MajorTopicYN="N">Diagnostic Errors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015483" MajorTopicYN="N">HIV Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015498" MajorTopicYN="N">HIV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014397" MajorTopicYN="N">Tuberculosis, Pulmonary</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1406459</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Ghana</li></country></list><tree><noCountry><name sortKey="Das, P K" sort="Das, P K" uniqKey="Das P" first="P K" last="Das">P K Das</name><name sortKey="Van Den Akker, R" sort="Van Den Akker, R" uniqKey="Van Den Akker R" first="R" last="Van Den Akker">R. Van Den Akker</name><name sortKey="Van Der Mark, T W" sort="Van Der Mark, T W" uniqKey="Van Der Mark T" first="T W" last="Van Der Mark">T W Van Der Mark</name><name sortKey="Van Soolingen, D" sort="Van Soolingen, D" uniqKey="Van Soolingen D" first="D" last="Van Soolingen">D. Van Soolingen</name><name sortKey="Yong, S" sort="Yong, S" uniqKey="Yong S" first="S" last="Yong">S. Yong</name></noCountry><country name="Ghana"><noRegion><name sortKey="Van Der Werf, T S" sort="Van Der Werf, T S" uniqKey="Van Der Werf T" first="T S" last="Van Der Werf">T S Van Der Werf</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000847 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000847 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:1406459
|texte= Sero-diagnosis of tuberculosis with A60 antigen enzyme-linked immunosorbent assay: failure in HIV-infected individuals in Ghana.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:1406459" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |